Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium Falciparum [Phase 2]

View source ↗

Summary

A phase 2 randomized, double-blind trial assessing increasing weekly doses of tafenoquine for chemosuppression of Plasmodium falciparum malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Tafenoquine (tafenoquine)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Malaria | Phase 2 | Status: COMPLETED